Reports Library Publication
Insight Consumer Healthcare Europe June / July 2026
16th July 2026 by CHC Insight
1. Analgesics Cost cutting drives private labels
2. Gender Pain Gap Women continue to feel their pain is minimised or dismissed
3. Stada Health Report Consumers using AI as a tool to support health & wellness
4. Innovation Round-up GLP-1 support segment growing
5. News Review Stada eyeing Cooper CH deal?
Order this report
Why buy this report?
"Analgesics sales slowed vs the year-ago period as consumers continued to seek cheaper alternatives in the difficult economic climate. Marketers invested in high-strength ibuprofen, combination products and dexibuprofen launches in several markets to differentiate and protect brands from rising PL and generic competitors. Russia recorded a high level of market-first launches, including ibuprofen + diphenhydramine, which is a regional first in the growing night pain niche. Other key developments included Haleon’s rollout of topical VoltaHeat patches and warming gel in France and UK."
Nicholas Hall